From Textbooks to Platforms: Why Medical Publishing Now Needs Common Rules
Professional medical books are no longer produced only by venerable publishers and quietly catalogued in library systems. Today, they appear on Amazon and Google Play Books, circulate as PDFs and e‑books shared through ResearchGate, and coexist with classic titles in institutional collections. This is not a marginal change. It is a structural shift that affects how we create, distribute, index, and judge medical knowledge.
In this new real‑virtual ecosystem, the old and new worlds of publishing are tightly entangled. The same underlying pressures and diseases—competition, metric obsession, and manipulation—now surface across traditional journals, commercial e‑book platforms, and academic social networks. That is why we need common rules and shared standards that apply to all channels, not just to one platform or one segment of the industry.
1. From classic gatekeepers to platform ecologies
For most of the 20th century, established medical and academic publishers combined two functions: they produced books and journals, and they acted as gatekeepers to the formal record of medical knowledge. Editorial boards and peer review shaped what entered the literature; library catalogues and indexing systems such as the National Library of Medicine classification made it discoverable and stable.
In that older model:
Acceptance by a reputable journal or medical publisher normally implied a minimum level of scientific and editorial scrutiny.
Inclusion in Medline, Bookshelf, or a university library catalogue embedded a work in a curated infrastructure with clear collection policies.
Competition existed, but it was filtered through editorial decision‑making and library selection, not through global algorithms.
Today, that landscape is much more complex:
Amazon and Google Play Books allow medical authors to bypass traditional gatekeepers, self‑publish monographs, exam guides, or handbooks, and reach a global audience with indexing driven largely by categories, keywords, sales rank, and user reviews.
ResearchGate and similar academic social networks host articles, chapters, and sometimes entire books inside a “scientific bubble,” where discoverability depends on platform metrics (reads, recommendations, scores) and social connections.
Traditional publishers themselves now compete aggressively in a crowded market, sometimes prioritizing output volume and visibility in metrics over careful selectivity.
We no longer have a single, coherent medical publishing system. We have a multi‑layered ecology in which old and new channels interact and compete, often under similar incentive structures.
2. Democratization and its gains
The emergence of Amazon, Google Play, ResearchGate, and other digital platforms is not simply a threat. It has delivered genuine, important benefits for medicine and medical education.
Broader participation and new voices
Self‑publishing and platform‑based dissemination lower barriers for clinicians, trainees, educators, and authors in under‑represented regions. Some self‑published works—such as unique historical accounts or locally grounded medical narratives—are now recognized as valuable enough to be selectively collected by major medical libraries. This widens the epistemic map beyond what a handful of large houses can cover.Speed and adaptability
Traditional textbooks can take years to move from proposal to publication, and new editions lag behind changes in guidelines, curricula, or technology. In contrast, digital self‑publishing lets authors update clinical handbooks, exam prep materials, and educational monographs in weeks, aligning them with emerging evidence, new assessment formats, or fast‑moving fields such as AI in medicine and telehealth.Integration with real‑virtual education
Modern medical learning already spans classrooms, hospitals, simulation centers, and digital environments. Platforms and tools for digital medical publishing support interactive cases, multimedia, analytics, and integration with learning management systems. ResearchGate and institutional repositories sit inside this “scientific bubble,” linking texts with metrics, comments, and related work. E‑books on Amazon and Google Play travel easily across devices and learning contexts.
Seen from this angle, democratized publishing acts as a social control instrument in a positive sense: communities of practice gain the ability to create, critique, and iterate on educational and clinical content more rapidly and more visibly than when everything passed through a small number of gates.
3. The common disease: publication integrity under metric pressure
Democratization did not invent our integrity problems; it exposed and amplified a disease that was already present in the traditional system.
Manipulation in the new platforms
ResearchGate can be gamed by fake profiles, AI‑generated “papers,” and citation‑farming rings that inflate apparent impact. Suspicious accounts have been created purely to boost metrics, sometimes using fabricated identities and recycled content, with effects that spill over into search engines and citation indices.
On commercial platforms like Amazon and Google Play, visibility depends on categories, user ratings, and sales patterns that can be influenced by coordinated purchasing, review manipulation, and aggressive marketing, including in health‑related categories.
Manipulation in the old system
Similar issues have been documented within classic journals and book series:
There is now detailed guidance on “systematic manipulation of the publication process,” including paper mills, fabricated data, fake peer review, and citation cartels, all of which have affected mainstream journals.
Publishers have had to retract large clusters of articles once patterns of fraud or manipulation became evident, and they are building new integrity checks and workflows to respond.
Analyses of publication integrity argue that over‑reliance on publication counts, impact factors, and simple citation metrics creates strong incentives to game the system, regardless of whether outputs appear in print journals or on digital platforms.
Competition among journals and series has led to a dispersion of quality even within the traditional bubble, especially when high volume and metric visibility are rewarded. The same forces that push authors to game ResearchGate or Amazon rankings also push them to exploit weaknesses in peer review and citation systems.
We are facing a system‑wide integrity problem, not a simple “bad platform versus good old publishers” dichotomy.
4. Indexing and discoverability in a fragmented map
Indexing used to be a conservative filter and a map‑making exercise. Systems such as the National Library of Medicine classification, Medline, and curated library catalogues decided what counted as part of the referenceable medical literature and where it belonged.
Now, three logics coexist:
Conservative institutional indexing
Major medical libraries maintain strict criteria for inclusion. For self‑published or independently sponsored books, they may require notability, endorsement by reputable organizations, and clear peer‑review or editorial processes. This selectivity is a deliberate response to the massive and uneven growth of digital content.Commercial platform indexing
Amazon and Google Play “index” all the books they sell, but their categories and ranking systems are designed for commerce and engagement, not for epistemic reliability. A book’s visibility is driven by purchasing behavior, reviews, and internal algorithms.Social‑metric indexing
ResearchGate builds a map of the literature inside an academic social network, where metrics such as reads, recommendations, and composite scores heavily influence what users see. Citation‑farming and similar practices can systematically inflate these metrics.
Because these three logics are not harmonized, discoverability and perceived authority no longer align reliably with quality. A carefully reviewed textbook might be “buried” on commercial platforms, while a weak or misleading work can be algorithmically amplified or socially boosted.
5. Personal responsibility in a real‑virtual publishing world
In the classic model, a significant share of responsibility for what entered the public domain fell on editors, publishers, and the institutions that indexed and collected works. Authors were still responsible, but they operated inside strong external filters.
In the new real‑virtual dimension:
A single author can publish a medical book worldwide via Amazon or Google Play without formal peer review.
The same author can upload versions, fragments, or related materials to ResearchGate, where they become indexed and cited within the scientific bubble.
Many readers will encounter these works directly through platform algorithms, without the contextual cues provided by library selection, journal branding, or inclusion in curated collections.
This means that the personal responsibility of the author—ethical, professional, and ultimately legal—for the integrity and potential impact of medical content is significantly increased. Authors cannot rely on a publisher’s reputation or a library’s collection policies as the only guarantors of quality.
Existing legal frameworks around fraudulent or misleading health claims already apply, but they were not designed with this highly distributed, rapidly updating ecosystem in mind. As self‑publishing and platform distribution become central channels for medical information, there is a strong argument for:
Clarifying how duties of care, disclosure, and honesty apply to authors who publish medical content directly to the public and professional audiences.
Ensuring that obligations of transparency (authorship, conflicts of interest, evidence basis) are enforceable across formats and platforms, not only in traditional journals.
Democratization expands freedom but must be accompanied by clearer, stronger expectations of author responsibility.
6. Why we now need common rules across all channels
It is neither realistic nor desirable to return to a world where a few big houses monopolize medical publishing. The gains from democratization—diverse voices, speed, integration with digital learning—are too important.
At the same time, competition among traditional journals and book series has already dispersed quality within the old system. The emergence of Amazon, Google Play, ResearchGate, and similar platforms adds more layers where the same integrity problems can appear, often with fewer safeguards.
This coexistence of traditional publishers, commercial platforms, and academic social networks demands new, shared policies and rules that apply to all of them. Key elements could include:
Shared integrity standards for transparency, authorship, conflicts of interest, and correction or retraction procedures, regardless of where a work is hosted.
Clear tagging of review status—peer‑reviewed, editorially reviewed, or unreviewed—visible to readers on all major platforms.
Cross‑platform integrity cooperation, so that signs of paper mills, fake identities, and citation‑farming can be addressed collaboratively.
Reformed evaluation practices that rely less on raw counts and more on qualitative assessment of contribution and integrity.
Education in platform and metric literacy for students, clinicians, and educators.
The democratization of medical publishing is not the problem; it is an opportunity to redesign our social control instruments for a real‑virtual world. The question is whether we, as a community, are ready to formulate and adopt cross‑platform rules that recognize the shared nature of our integrity problems and make explicit the responsibilities of authors, publishers, platforms, and institutions.
The time to do so has already arrived.
Mykola Iabluchanskyi, Andriy Yabluchanskiy
Comments